Role of inflammation in drug induced liver injury (DILI)

被引：0
|
作者：
Tannenbaum, Steven R. [1 ]
机构：
[1] MIT, Dept Chem, Cambridge, MA 02139 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
10-TOXI
引用
收藏
页数：1
相关论文
共 50 条
  • [41] UTILITY OF A NOVEL DRUG INDUCED LIVER INJURY CAUSALITY ASSESSMENT TOOL (DILI-CAT) FOR ADJUDICATION OF DILI IN DRUG DEVELOPMENT.
    Faasld, Hans L. Tillmann. Md.
    Rockey, Don C.
    Suzuki, Ayako
    Merz, Michael
    Herrmann, Richard
    HEPATOLOGY, 2020, 72 : 731A - 732A
  • [42] Case of cholestatic drug-induced liver injury (DILI) associated with black cohosh
    Brar, Himmat Singh
    Marathi, Rachana
    BMJ CASE REPORTS, 2021, 14 (05)
  • [43] Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
    Danjuma, Mohammed
    Elgara, Mohamed
    Al-Hattab, Fatima
    Abaro, Rumaisa
    Elzouki, Abdel-Naser
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (07) : 934 - 935
  • [44] Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
    Juliana Hey-Hadavi
    Daniel Seekins
    Melissa Palmer
    Denise Coffey
    John Caminis
    Sandzhar Abdullaev
    Meenal Patwardhan
    Haifa Tyler
    Ritu Raheja
    Ann Marie Stanley
    Liliam Pineda-Salgado
    David L. Bourdet
    Raul J. Andrade
    Paul H. Hayashi
    Lara Dimick-Santos
    Don C. Rockey
    Alvin Estilo
    Drug Safety, 2021, 44 : 619 - 634
  • [45] Phenotypic and genotypic characterization of drug-induced liver injury (DILI) with autoimmune features
    Stephens, C.
    Ortega, A.
    Medina-Caliz, I.
    Diaz, Mercedes Robles
    Castiella, Agustin
    Otazua, Pedro
    Zapata, E.
    Gomez-Moreno, E. M.
    Lopez-Nevot, MAngel
    Ruiz-Cabello, Francisco
    Soriano, German
    Roman, E.
    Hallal, Hacibe
    Maria Moreno-Planas, Jose
    Prieto, Martin
    Lucena, M. I.
    Andrade, Raul J.
    HEPATOLOGY, 2015, 62 : 499A - 499A
  • [46] The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury
    Thakkar, Shraddha
    Chen, Minjun
    Fang, Hong
    Liu, Zhichao
    Roberts, Ruth
    Tong, Weida
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 12 (01) : 31 - 38
  • [47] THE REDISCOVERY OF HepG2 CELLS FOR PREDICTION OF DRUG INDUCED LIVER INJURY (DILI)
    Ghallab, Ahmed
    EXCLI JOURNAL, 2014, 13 : 1286 - 1288
  • [48] Autoimmune hepatitis (AIH) or drug-Induced liver injury (DILI)-a diagnostic challenge
    Maor, Yaakov
    Abdallah, Ali
    Mendel, Leore Cohen
    Melzer, Ehud
    Malnick, Stephen
    JOURNAL OF HEPATOLOGY, 2023, 78 : S133 - S133
  • [49] Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
    Hey-Hadavi, Juliana
    Seekins, Daniel
    Palmer, Melissa
    Coffey, Denise
    Caminis, John
    Abdullaev, Sandzhar
    Patwardhan, Meenal
    Tyler, Haifa
    Raheja, Ritu
    Stanley, Ann Marie
    Pineda-Salgado, Liliam
    Bourdet, David L.
    Andrade, Raul J.
    Hayashi, Paul H.
    Dimick-Santos, Lara
    Rockey, Don C.
    Estilo, Alvin
    DRUG SAFETY, 2021, 44 (06) : 619 - 634
  • [50] Highlight report: prediction of drug induced liver injury (DILI) with human hepatocytes in vitro
    Albrecht, Wiebke
    ARCHIVES OF TOXICOLOGY, 2017, 91 (12) : 4021 - 4022
12345